comparemela.com

Latest Breaking News On - Director linda palczuk - Page 2 : comparemela.com

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of Buy by Brokerages

Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) have received a consensus rating of “Buy” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have covered the stock in the last […]

Avadel Pharmaceuticals (NASDAQ:AVDL) PT Raised to $18 00 at Craig Hallum

Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) had its target price increased by Craig Hallum from $16.00 to $18.00 in a report released on Friday morning, The Fly reports. A number of other equities analysts have also weighed in on the company. Lifesci Capital reiterated an outperform rating on shares of Avadel Pharmaceuticals in a research […]

Avadel Pharmaceuticals (NASDAQ:AVDL) Trading 4 5% Higher

Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Rating) traded up 4.5% during trading on Thursday . The company traded as high as $15.13 and last traded at $15.02. 590,915 shares traded hands during mid-day trading, a decline of 18% from the average session volume of 719,685 shares. The stock had previously closed at $14.37. […]

Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $15 25

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Rating) shares gapped down before the market opened on Friday . The stock had previously closed at $15.25, but opened at $14.29. Avadel Pharmaceuticals shares last traded at $13.78, with a volume of 318,616 shares traded. Analyst Ratings Changes A number of equities analysts recently weighed in on the […]

Analysts Set Avadel Pharmaceuticals plc (NASDAQ:AVDL) PT at $13 44

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Rating) has been assigned an average rating of “Buy” from the seven analysts that are covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have updated their coverage on the stock in […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.